These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 16076960)

  • 21. Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes.
    Kim YK; Kwak MJ; Ku B; Suh HY; Joo K; Lee J; Jung JU; Oh BH
    Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1587-97. PubMed ID: 23897481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases.
    Mahrour N; Redwine WB; Florens L; Swanson SK; Martin-Brown S; Bradford WD; Staehling-Hampton K; Washburn MP; Conaway RC; Conaway JW
    J Biol Chem; 2008 Mar; 283(12):8005-13. PubMed ID: 18187417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase.
    Wang H; Lv G; Zhou X; Li Z; Liu X; Yu XF; Zhang W
    BMC Microbiol; 2014 Nov; 14():290. PubMed ID: 25424878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
    Kamura T; Maenaka K; Kotoshiba S; Matsumoto M; Kohda D; Conaway RC; Conaway JW; Nakayama KI
    Genes Dev; 2004 Dec; 18(24):3055-65. PubMed ID: 15601820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
    Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
    Zhang W; Huang M; Wang T; Tan L; Tian C; Yu X; Kong W; Yu XF
    Cell Microbiol; 2008 Aug; 10(8):1662-75. PubMed ID: 18419775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.
    Dang Y; Wang X; Zhou T; York IA; Zheng YH
    J Virol; 2009 Sep; 83(17):8544-52. PubMed ID: 19535447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Vif-induced APOBEC3G degradation using an alpha-complementation assay.
    Fang L; Landau NR
    Virology; 2007 Mar; 359(1):162-9. PubMed ID: 17049578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular structure and biochemical properties of the HCCH-Zn2+ site in HIV-1 Vif.
    Giri K; Scott RA; Maynard EL
    Biochemistry; 2009 Aug; 48(33):7969-78. PubMed ID: 19588889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
    Dang Y; Wang X; York IA; Zheng YH
    J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
    Newman EN; Holmes RK; Craig HM; Klein KC; Lingappa JR; Malim MH; Sheehy AM
    Curr Biol; 2005 Jan; 15(2):166-70. PubMed ID: 15668174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.
    Bergeron JR; Huthoff H; Veselkov DA; Beavil RL; Simpson PJ; Matthews SJ; Malim MH; Sanderson MR
    PLoS Pathog; 2010 Jun; 6(6):e1000925. PubMed ID: 20532212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
    Zhang W; Du J; Evans SL; Yu Y; Yu XF
    Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions.
    Paul I; Cui J; Maynard EL
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18475-80. PubMed ID: 17132731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
    Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
    Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid evolution of primate antiviral enzyme APOBEC3G.
    Zhang J; Webb DM
    Hum Mol Genet; 2004 Aug; 13(16):1785-91. PubMed ID: 15198990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
    Zhou X; Evans SL; Han X; Liu Y; Yu XF
    PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.
    Opi S; Kao S; Goila-Gaur R; Khan MA; Miyagi E; Takeuchi H; Strebel K
    J Virol; 2007 Aug; 81(15):8236-46. PubMed ID: 17522211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation.
    Knecht KM; Hu Y; Rubene D; Cook M; Ziegler SJ; Jónsson SR; Xiong Y
    J Biol Chem; 2021; 296():100045. PubMed ID: 33465707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.